Insider · CIK 0001829248
Polly A. Murphy
Files at AVIR (Atea Pharmaceuticals, Inc.), CELC (Celcuity Inc.). First filing May 20, 2026, latest May 20, 2026.
Polly A. Murphy files SEC Form 4 as director at AVIR (Atea Pharmaceuticals, Inc.), and also at CELC (Celcuity Inc.). Since May 20, 2026, Polly A. Murphy has reported 1 open-market buy worth $25k and 0 open-market sells worth $0, the latest filed on May 20, 2026.
A track record needs three past buys with six months of prices behind them; Polly A. Murphy has 0, so none is measured yet.
The newest scored trade: bought $25k of AVIR on May 18, 2025, filed May 20, 2026, scored 41 (moderate). In the last 12 months: 1 buy worth $25k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AVIR: Atea Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | AVIRbuy Atea Pharmaceuticals, Inc. | $25k 6,100 shares | +7% | +7% from low-32% from high |
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Common Stock | +29,600 | $0.00 | $0 | 121,745 | Jun 23, 2026 |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -29,600 | $0.00 | $0 | 0 | Jun 23, 2026 |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +26,700 | $0.00 | $0 | 26,700 | Jun 23, 2026 |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +37,700 | $0.00 | $0 | 37,700 | Jun 23, 2026 |
| Jun 10, 2026 | CELC Celcuity Inc. | GGift Stock Option (right to buy)derivative | -14,048 | $0.00 | $0 | 0 | Jun 12, 2026 |
| Jun 10, 2026 | CELC Celcuity Inc. | GGift Stock Option (right to buy)derivativeindirect: By Trust | +14,048 | $0.00 | $0 | 14,048 | Jun 12, 2026 |
| Jun 5, 2026 | CELC Celcuity Inc. | AGrant or award Common Stock | +1,530 | $0.00 | $0 | 6,530 | Jun 9, 2026 |
| May 18, 2025 | AVIR Atea Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +6,100 | $4.17 | $25k | 92,145 | May 20, 2026 |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Common Stock | +29,600 | $0.00 | $0 | 86,045 | Jun 24, 2025 |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +29,600 | $0.00 | $0 | 29,600 | Jun 24, 2025 |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +41,200 | $0.00 | $0 | 41,200 | Jun 24, 2025 |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -29,600 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 24, 2024 | CELC Celcuity Inc. | GGift Stock Option (right to buy)derivative | -16,300 | $0.00 | $0 | 0 | May 29, 2025 |
| Jun 24, 2024 | CELC Celcuity Inc. | GGift Stock Option (right to buy)derivativeindirect: By Trust | +16,300 | $0.00 | $0 | 16,300 | May 29, 2025 |
| Jun 24, 2024 | CELC Celcuity Inc. | GGift Stock Option (right to buy)derivative | -11,645 | $0.00 | $0 | 0 | May 29, 2025 |
| Jun 24, 2024 | CELC Celcuity Inc. | GGift Stock Option (right to buy)derivativeindirect: By Trust | +11,645 | $0.00 | $0 | 11,645 | May 29, 2025 |
| May 28, 2025 | CELC Celcuity Inc. | GGift Stock Option (right to buy)derivative | -8,153 | $0.00 | $0 | 0 | May 29, 2025 |
| May 28, 2025 | CELC Celcuity Inc. | GGift Stock Option (right to buy)derivativeindirect: By Trust | +8,153 | $0.00 | $0 | 8,153 | May 29, 2025 |
| May 19, 2025 | CELC Celcuity Inc. | AGrant or award Stock Option (right to buy)derivative | +14,048 | $0.00 | $0 | 14,048 | May 21, 2025 |
Questions about Polly A. Murphy
Answered from the filings on this page, as of the latest one.
Is Polly A. Murphy buying or selling?
In the last 12 months Polly A. Murphy reported 1 open-market buy worth $25k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $25k of AVIR on May 18, 2025. Grants, option exercises and tax withholding are not counted.
How did Polly A. Murphy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Polly A. Murphy has 0.
Where does Polly A. Murphy file Form 4?
Polly A. Murphy has filed Form 4 at AVIR (Atea Pharmaceuticals, Inc.); CELC (Celcuity Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.